203 related articles for article (PubMed ID: 25629310)
1. Recent developments in therapeutic applications of Cyanobacteria.
Raja R; Hemaiswarya S; Ganesan V; Carvalho IS
Crit Rev Microbiol; 2016 May; 42(3):394-405. PubMed ID: 25629310
[TBL] [Abstract][Full Text] [Related]
2. Developments of Cyanobacteria for Nano-Marine Drugs: Relevance of Nanoformulations in Cancer Therapies.
Bajpai VK; Shukla S; Kang SM; Hwang SK; Song X; Huh YS; Han YK
Mar Drugs; 2018 May; 16(6):. PubMed ID: 29882898
[TBL] [Abstract][Full Text] [Related]
3. Health applications of bioactive compounds from marine microalgae.
de Jesus Raposo MF; de Morais RM; de Morais AM
Life Sci; 2013 Oct; 93(15):479-86. PubMed ID: 23994664
[TBL] [Abstract][Full Text] [Related]
4. Cyanobacteria-derived peptide antibiotics discovered since 2000.
Xue Y; Zhao P; Quan C; Zhao Z; Gao W; Li J; Zu X; Fu D; Feng S; Bai X; Zuo Y; Li P
Peptides; 2018 Sep; 107():17-24. PubMed ID: 30077717
[TBL] [Abstract][Full Text] [Related]
5. Antifungal compounds from cyanobacteria.
Shishido TK; Humisto A; Jokela J; Liu L; Wahlsten M; Tamrakar A; Fewer DP; Permi P; Andreote AP; Fiore MF; Sivonen K
Mar Drugs; 2015 Apr; 13(4):2124-40. PubMed ID: 25871291
[TBL] [Abstract][Full Text] [Related]
6. Phycobiliproteins: A Novel Green Tool from Marine Origin Blue-Green Algae and Red Algae.
Chandra R; Parra R; Iqbal HM
Protein Pept Lett; 2017; 24(2):118-125. PubMed ID: 27491380
[TBL] [Abstract][Full Text] [Related]
7. Bioactive compounds from cyanobacteria and microalgae: an overview.
Singh S; Kate BN; Banerjee UC
Crit Rev Biotechnol; 2005; 25(3):73-95. PubMed ID: 16294828
[TBL] [Abstract][Full Text] [Related]
8. A review of pharmacological and toxicological potentials of marine cyanobacterial metabolites.
Nagarajan M; Maruthanayagam V; Sundararaman M
J Appl Toxicol; 2012 Mar; 32(3):153-85. PubMed ID: 21910132
[TBL] [Abstract][Full Text] [Related]
9. Biomedicinals from the phytosymbionts of marine invertebrates: a molecular approach.
Dunlap WC; Battershill CN; Liptrot CH; Cobb RE; Bourne DG; Jaspars M; Long PF; Newman DJ
Methods; 2007 Aug; 42(4):358-76. PubMed ID: 17560324
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of the novel bioactive compounds from microalgae and cyanobacteria for pharmaceutical and nutraceutical applications.
Hassan S; Meenatchi R; Pachillu K; Bansal S; Brindangnanam P; Arockiaraj J; Kiran GS; Selvin J
J Basic Microbiol; 2022 Sep; 62(9):999-1029. PubMed ID: 35014044
[TBL] [Abstract][Full Text] [Related]
11. Exploitation of marine algae: biogenic compounds for potential antifouling applications.
Bhadury P; Wright PC
Planta; 2004 Aug; 219(4):561-78. PubMed ID: 15221382
[TBL] [Abstract][Full Text] [Related]
12. Contamination by Microcystis and microcystins of blue-green algae food supplements (BGAS) on the Italian market and possible risk for the exposed population.
Vichi S; Lavorini P; Funari E; Scardala S; Testai E
Food Chem Toxicol; 2012 Dec; 50(12):4493-9. PubMed ID: 23036452
[TBL] [Abstract][Full Text] [Related]
13. Nanosynthesis, phycochemical constituents, and pharmacological properties of cyanobacterium Oscillatoria sp.
Bishoyi AK; Mandhata CP; Sahoo CR; Paidesetty SK; Padhy RN
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1347-1375. PubMed ID: 37712972
[TBL] [Abstract][Full Text] [Related]
14. Structural Diversity, Biological Properties and Applications of Natural Products from Cyanobacteria. A Review.
Shah SAA; Akhter N; Auckloo BN; Khan I; Lu Y; Wang K; Wu B; Guo YW
Mar Drugs; 2017 Nov; 15(11):. PubMed ID: 29125580
[TBL] [Abstract][Full Text] [Related]
15. Hepatopathy following consumption of a commercially available blue-green algae dietary supplement in a dog.
Bautista AC; Moore CE; Lin Y; Cline MG; Benitah N; Puschner B
BMC Vet Res; 2015 Jun; 11():136. PubMed ID: 26087767
[TBL] [Abstract][Full Text] [Related]
16. Antifouling potential of cyanobacteria: a mini-review.
Dahms HU; Ying X; Pfeiffer C
Biofouling; 2006; 22(5-6):317-27. PubMed ID: 17110355
[TBL] [Abstract][Full Text] [Related]
17. Biologically active substances produced by antarctic cryptoendolithic fungi.
Ocampo-Friedmann R; Friedmann EI
Antarct J US; 1993; 28(5):252-4. PubMed ID: 11539461
[TBL] [Abstract][Full Text] [Related]
18. Out in the green: biologically active metabolites produced by cyanobacteria.
Gademann K
Chimia (Aarau); 2011; 65(6):416-9. PubMed ID: 21797171
[TBL] [Abstract][Full Text] [Related]
19. Influence of light intensity, temperature and CO₂ concentration on growth and lipids in green algae and cyanobacteria.
Shukla M; Tabassum R; Singh R; Dhar DW
Indian J Exp Biol; 2016 Jul; 54(7):482-487. PubMed ID: 29466628
[TBL] [Abstract][Full Text] [Related]
20. A Review Study on Macrolides Isolated from Cyanobacteria.
Wang M; Zhang J; He S; Yan X
Mar Drugs; 2017 Apr; 15(5):. PubMed ID: 28445442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
